Cymat Competitors

CYMHF Stock

USD 0.14 0.02 12.50%

Cymat Technologies competes with Maanshan Iron, Ternium SA, Coca Cola, Diageo PLC, and Allegheny Technologies; as well as few others. The company classifies itself under Metals & Mining sector and is part of Materials industry. Analyzing Cymat Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Cymat Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Cymat Technologies Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Cymat Technologies competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.01	0.14	10.70

Details

Intrinsic

Valuation

Low	Real	High
0.01	0.11	10.67

Details

Naive

Forecast

Low	Next	High
0	0.12	10.68

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
0.13	0.15	0.16

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cymat Technologies. Your research has to be compared to or analyzed against Cymat Technologies' peers to derive any actionable benefits. When done correctly, Cymat Technologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cymat Technologies.

Cymat Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Cymat Technologies and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Cymat and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Cymat Technologies does not affect the price movement of the other competitor.

	MAANF	TX	KO	DEO	ABVG	ATI	KALU	GGB
MAANF		0.65	-0.36	-0.8	0.0	0.81	0.77	0.79	MAANF
TX	0.65		-0.56	-0.58	0.0	0.84	0.92	0.78	TX
KO	-0.36	-0.56		0.44	0.0	-0.59	-0.56	-0.39	KO
DEO	-0.8	-0.58	0.44		0.0	-0.57	-0.6	-0.65	DEO
ABVG	0.0	0.0	0.0	0.0		0.0	0.0	0.0	ABVG
ATI	0.81	0.84	-0.59	-0.57	0.0		0.95	0.83	ATI
KALU	0.77	0.92	-0.56	-0.6	0.0	0.95		0.84	KALU
GGB	0.79	0.78	-0.39	-0.65	0.0	0.83	0.84		GGB
	MAANF	TX	KO	DEO	ABVG	ATI	KALU	GGB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

KALU	+ 0.95	ATI
KALU	+ 0.92	TX
ATI	+ 0.84	TX
GGB	+ 0.84	KALU
GGB	+ 0.83	ATI
ATI	+ 0.81	MAANF

High negative correlations

DEO	- 0.8	MAANF
GGB	- 0.65	DEO
KALU	- 0.6	DEO
ATI	- 0.59	KO
DEO	- 0.58	TX
ATI	- 0.57	DEO

Risk-Adjusted Indicators

There is a big difference between Cymat OTC Stock performing well and Cymat Technologies OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cymat Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MAANF	0.14	0.06	0.00	(5.12)	0.00	0.00	0.00	0.00	4.55
TX	1.44	0.23	0.10	0.72	1.19	(1.81)	3.66	(2.19)	8.83
KO	0.75	(0.08)	0.00	(0.26)	0.00	0.00	1.55	(1.28)	4.81
DEO	1.06	(0.15)	0.00	(0.27)	0.00	0.00	2.20	(2.26)	8.07
ABVG	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ATI	1.57	0.90	0.61	0.91	0.58	(2.07)	5.06	(2.64)	17.43
KALU	1.71	0.58	0.50	0.52	0.60	(2.18)	5.30	(1.96)	9.01
GGB	1.77	0.11	0.03	0.30	1.74	(2.22)	4.80	(3.17)	10.58

Unable to evaluate fundamental data of [MAANF, TX, KO, DEO, ABVG, ATI, KALU, GGB] at this time. Please try again later

All Fundamental Data

Cymat Technologies Competitive Analysis

The better you understand Cymat Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Cymat Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Cymat Technologies' competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	CYMHF	MAANF	TX	KO	DEO	ATI	KALU	GGB
	12.50 0.14 Cymat	0.00 0.23 Maanshan	1.04 30.36 Ternium	1.05 69.85 Coca	0.09 103.25 Diageo	0.91 93.41 Allegheny	0.47 89.68 Kaiser	2.73 2.85 Gerdau
Market Volatility (90 Days Market Risk)	Out of control	Dangerous	Very steady	Very steady	Very steady	Very steady	Very steady	Moderately volatile
Market Performance (90 Days Performance)	OK	OK	Good	Very Weak	Very Weak	Very Strong	Strong	OK
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Below Average	Low	Low	Low	Very Small	Very Small	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Under Valued	Under Valued	Fairly Valued	Over Valued	Over Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Buy	Strong Buy	Buy	Strong Buy	Buy	Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Buy	Cautious Hold	Strong Hold	Strong Buy	Strong Buy	Strong Hold
Current Ratio	2.19 X	0.86 X	4.21 X	1.13 X	1.53 X	2.88 X	2.41 X	2.22 X
Net Asset	6.17 M	91.21 B	23.13 B	100.55 B	45.47 B	5.23 B	2.31 B	86.81 B
Profit Margin	(1.47) %	(0) %	(0.02) %	0.23 %	0.18 %	0.09 %	0.02 %	0.05 %
EBITDA	(4.23 M)	10.9 B	1.88 B	15.81 B	7.24 B	608.9 M	223.6 M	9.39 B
Operating Margin	(1.35) %	(0) %	0.03 %	0.34 %	0.29 %	0.13 %	0.05 %	0.08 %
Current Valuation	14.54 M	4.01 B	4.89 B	335.98 B	76.06 B	14.59 B	2.5 B	7.31 B
Price To Book	9.24 X	0.36 X	0.49 X	11.47 X	5.49 X	7.04 X	1.91 X	0.57 X
Retained Earnings	N/A	3.34 B	13.18 B	76.05 B	7.53 B	64.3 M	6.2 M	24.24 B
Current Asset	N/A	20.42 B	2.58 B	33.4 B	8.85 B	1.87 B	501.6 M	2 K
Five Year Return	N/A	N/A	4.82 %	3.13 %	2.24 %	2.44 %	2.77 %	3.57 %
Beta	0.7	1.16	1.42	0.46	0.28	1.13	1.43	0.89
Number Of Employees	12	18.73 K	33.95 K	69.7 K	30.09 K	7.8 K	3.9 K	30 K
Shares Outstanding	59.09 M	1.73 B	196.31 M	4.3 B	555.58 M	141.07 M	16.15 M	1.28 B
Cash Flow From Operations	(4.32 M)	16.77 B	1.91 B	6.8 B	6.07 B	407.2 M	167.1 M	11.38 B
Annual Yield	N/A	0.24 %	0.09 %	0.03 %	0.04 %	N/A	0.04 %	0.04 %
Total Debt	123.93 K	5.45 B	2.44 B	44.52 B	21.5 B	1.9 B	1.08 B	14.92 B
Return On Equity	-2.41	-0.0118	-0.0103	0.39	0.32	0.25	0.0706	0.061
Z Score	96.6	1.0	N/A	N/A	N/A	N/A	N/A	N/A
Return On Asset	-0.55	-0.0019	0.0171	0.0889	0.0772	0.0728	0.0287	0.0447
Book Value Per Share	0.03 X	3.95 X	61.68 X	6.09 X	4.63 X	13.28 X	47.29 X	27.61 X
Number Of Shares Shorted	N/A	N/A	1.01 M	36.84 M	522.11 K	4.28 M	395.96 K	12.84 M
Current Liabilities	N/A	29.76 B	1.7 B	26.93 B	6.19 B	686.5 M	169.3 M	1.59 B
Total Asset	6.17 M	91.21 B	23.13 B	100.55 B	45.47 B	5.23 B	2.31 B	86.81 B
Debt To Equity	0.88 %	0.43 %	0.1 %	1.69 %	1.76 %	1.84 %	1.69 %	0.28 %
Last Dividend Paid	N/A	0.35	2.7	1.97	1.03	N/A	3.08	0.64
Short Ratio	N/A	N/A	6.87 X	2.63 X	0.72 X	2.28 X	3.43 X	0.85 X
Target Price	N/A	N/A	35.96	77.83	126.14	80.89	64.0	4.23
Shares Owned By Institutions	2.38 %	10.64 %	15.70 %	65.27 %	9.97 %	96.24 %	95.60 %	24.50 %
Market Capitalization	19.99 M	3.01 B	5.96 B	300.65 B	58.11 B	13.18 B	1.45 B	5.74 B
Price To Earning	(2.98) X	2.90 X	2.25 X	27.50 X	69.32 X	153.89 X	297.18 X	21.61 X
Price To Earnings To Growth	N/A	N/A	4.03 X	4.32 X	1.47 X	1.20 X	2.24 X	N/A
Price To Sales	5.26 X	0.03 X	0.35 X	6.41 X	2.88 X	2.95 X	0.47 X	0.08 X
Net Income	(4.75 M)	5.33 B	(53.67 M)	10.65 B	4.17 B	382.7 M	46.8 M	4.6 B
Earnings Per Share	(0.06) X	0.04 X	(1.80) X	2.49 X	6.45 X	2.76 X	3.06 X	0.28 X
Shares Owned By Insiders	6.28 %	20.99 %	N/A	9.87 %	N/A	0.98 %	1.77 %	N/A
Revenue	3.12 M	113.85 B	17.65 B	47.06 B	20.27 B	4.36 B	3.02 B	67.03 B
Working Capital	N/A	(9.34 B)	7.23 B	748 M	5.26 B	1.74 B	575.8 M	21.82 B
Cash And Equivalents	2.21 M	13.98 B	1.65 B	9.52 B	1.44 B	584 M	129.3 M	7.75 B
Cash Per Share	0.04 X	1.80 X	13.97 X	3.06 X	4.25 X	2.55 X	8.15 X	4.58 X
Gross Profit	795.48 K	13.5 B	2.3 B	28.64 B	12.24 B	951.9 M	350.7 M	8.73 B
Day Typical Price	0.14	0.23	30.49	70.13	103.51	93.25	90.06	2.87
Accumulation Distribution	N/A	N/A	0.0191	0.0123	0.0105	0.0125	0.0229	0.0374
Market Facilitation Index	N/A	N/A	0.59	0.87	1.09	1.17	2.09	0.11
Daily Balance Of Power	(9,223,372,036,855)	0.0	(0.54)	(0.85)	0.0826	0.7179	(0.20)	(0.73)
Period Momentum Indicator	(0.02)	N/A	(0.32)	(0.74)	0.09	0.84	(0.42)	(0.08)
Rate Of Daily Change	0.88	1.0	0.99	0.99	1.0	1.01	1.0	0.97
Day Median Price	0.14	0.23	30.56	70.27	103.64	93.17	90.26	2.89
Price Action Indicator	(0.01)	N/A	(0.36)	(0.79)	(0.34)	0.66	(0.78)	(0.07)
Relative Strength Index	70.92	100.0	64.15	51.76	44.45	68.98	66.85	59.99
Coefficient Of Variation	1047.01	812.4	648.34	(2,390)	(1,516)	253.4	276.32	1124.04
Mean Deviation	4.63	0.1357	1.44	0.7523	1.06	1.57	1.71	1.77
Jensen Alpha	0.8195	0.0604	0.2269	(0.08)	(0.15)	0.8978	0.5785	0.1117
Total Risk Alpha	(0.47)	(0.02)	0.0164	(0.18)	(0.30)	0.6735	0.4711	(0.13)
Sortino Ratio	0.0509	N/A	0.1023	N/A	N/A	0.6103	0.5013	0.0335
Downside Variance	280.05	N/A	2.04	N/A	N/A	2.27	1.65	3.89
Standard Deviation	10.4	0.5595	1.86	0.9597	1.43	2.68	2.17	2.33
Kurtosis	14.54	66.0	0.5669	1.73	1.46	10.86	0.0181	0.9108
Potential Upside	15.38	N/A	3.66	1.55	2.2	5.06	5.3	4.8
Treynor Ratio	0.7849	(5.12)	0.7239	(0.26)	(0.27)	0.9056	0.5163	0.3022
Maximum Drawdown	69.77	4.55	8.83	4.81	8.07	17.43	9.01	10.58
Variance	108.18	0.313	3.46	0.921	2.03	7.21	4.7	5.41
Market Risk Adjusted Performance	0.7949	(5.11)	0.7339	(0.25)	(0.26)	0.9156	0.5263	0.3122
Risk Adjusted Performance	0.0983	0.1083	0.149	(0.04)	(0.06)	0.3751	0.3437	0.0891
Skewness	2.66	8.12	0.7571	0.8882	(0.42)	2.64	0.8227	0.77
Semi Deviation	5.44	N/A	1.19	N/A	N/A	0.5763	0.6038	1.74
Information Ratio	0.082	(0.13)	0.0785	(0.19)	(0.16)	0.3422	0.297	0.0284
Value At Risk	(12.50)	N/A	(2.19)	(1.28)	(2.26)	(2.64)	(1.96)	(3.17)
Expected Short fall	(16.27)	N/A	(1.81)	N/A	N/A	(2.07)	(2.18)	(2.22)
Downside Deviation	16.73	N/A	1.43	N/A	N/A	1.51	1.28	1.97
Semi Variance	29.54	N/A	1.42	N/A	N/A	0.3321	0.3646	3.03

Cymat Technologies Competition Performance Charts

Five steps to successful analysis of Cymat Technologies Competition

Cymat Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Cymat Technologies in relation to its competition. Cymat Technologies' competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Cymat Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Cymat Technologies' competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Cymat Technologies, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Cymat Technologies position

In addition to having Cymat Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cash Cows Thematic Idea Now

Cash Cows

Entities with stable and reliable earnings or profits, which allows them to pay consistent dividends to their shareholders. The Cash Cows theme has 25 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cash Cows Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Cymat OTC Stock

Cymat Technologies financial ratios help investors to determine whether Cymat OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cymat with respect to the benefits of owning Cymat Technologies security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Cymat Competitors

Specify up to 10 symbols:

Cymat Technologies Competition Correlation Matrix

Risk-Adjusted Indicators

Cymat Technologies Competitive Analysis

Cymat Technologies Competition Performance Charts

Five steps to successful analysis of Cymat Technologies Competition

Complement your Cymat Technologies position

Did You Try This Idea?

Run Cash Cows Thematic Idea Now

Cash Cows

Other Information on Investing in Cymat OTC Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY